|Bid||0.4205 x 1200|
|Ask||0.4223 x 800|
|Day's range||0.3894 - 0.4250|
|52-week range||0.3650 - 1.4700|
|Beta (5Y monthly)||0.61|
|PE ratio (TTM)||1.18|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
SESEN BIO, INC. (SESN) closed at $0.39 in the latest trading session, marking a -0.43% move from the prior day.
Wave Therapeutics (WVE) provides a positive update from its ongoing phase Ib/IIa study evaluating one of its lead candidates, WVE-003, for Huntington's disease. Stock up.
Puma Biotechnology (PBYI) inks license agreement with Japan's Takeda Pharmaceuticals, gaining worldwide development and commercialization rights to the latter's cancer treatment alisertib.